Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ring Closing Metathesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for Omarigliptin chiral intermediates via novel aldol condensation and RCM. Offers cost reduction and scalable supply for global pharmaceutical manufacturing.
Novel three-step synthesis method for high-purity bioorthogonal markers. Reduces complexity and enhances supply chain reliability for pharmaceutical research.
Patent CN113754666A details a safe, high-yield synthesis of benzopyrazine compounds using Ring-Closing Metathesis, offering reliable API intermediate supply chains.
Patent CN1774421A reveals a novel RCM-based route for Atorvastatin intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel route for Glecaprevir API intermediate avoids expensive reagents and improves yield. Reliable supplier for HCV drugs offering cost reduction in API manufacturing.
Patent CN111560017B reveals efficient synthesis of azabicyclo alkanone dipeptide mimetics. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel convergent route for diazaspirodec-2-one compounds reduces steps and metal contamination. Enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN119039223B reveals a high-yield route for nitrogen-containing heteroaromatic derivatives. Discover cost reduction in API manufacturing and scalable supply solutions.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.